HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Isolated limb infusion with cytotoxic agent for treatment of localized refractory cutaneous T-cell lymphoma.

Abstract
We described a 57-yr-old male diagnosed with cutaneous T-cell lymphoma that had failed multiple treatment options, as his disease was mainly confined to one limb. We attempted a novel approach in this condition using a technique of intra-arterial limb infusion with cytotoxic agent Melphalan (ILI) which has been proven beneficial in management of localised malignant melanoma. This treatment approach was well tolerated with mild myelosuppression and moderate limb toxicity. However, a significant improvement has been noted in the affected limb. This case demonstrated the successful use of isolated limb infusion with Melphalan in the management of localised cutaneous T-cell lymphoma. However, this result needs to be confirmed and further study is recommended. We are unaware there have been similar cases reported in the literature.
AuthorsE Elhassadi, E Egan, G O'sullivan, R Mohamed
JournalClinical and laboratory haematology (Clin Lab Haematol) Vol. 28 Issue 4 Pg. 279-81 (Aug 2006) ISSN: 0141-9854 [Print] England
PMID16898971 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antineoplastic Agents, Alkylating
  • Melphalan
Topics
  • Antineoplastic Agents, Alkylating (administration & dosage)
  • Chemotherapy, Cancer, Regional Perfusion (methods)
  • Humans
  • Lymphoma, T-Cell, Cutaneous (drug therapy, pathology)
  • Male
  • Melphalan (administration & dosage)
  • Middle Aged
  • Skin Neoplasms (drug therapy, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: